Sveriges mest populära poddar
Oncology Today with Dr Neil Love

What Clinicians Want to Know About the Current and Future Role of EZH1/2 Inhibitors in the Care of Patients with Lymphoma

56 min8 november 2024

Dr Gilles Salles from the Memorial Sloan Kettering Cancer Center in New York, New York, reviews current and novel EZH1/2 inhibitor-based treatment strategies for follicular lymphoma, moderated by Dr Neil Love. Produced by Research To Practice.

CME information and select publications here.

Fler avsnitt av Oncology Today with Dr Neil Love

Visa alla avsnitt av Oncology Today with Dr Neil Love

Oncology Today with Dr Neil Love med Dr. Neil Love finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.